Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

内科学 医学 多发性骨髓瘤 置信区间 肿瘤科 回顾性队列研究 微小残留病 无进展生存期 骨髓 外科 总体生存率
作者
K. Elias,Stefanie Huhn,Kaya Miah,Alexandra M. Poos,Christof Scheid,Katja Weisel,Uta Bertsch,Markus Munder,Oscar Berlanga,Dirk Hose,Anja Seckinger,Anna Jauch,Igor Wolfgang Blau,Mathias Hänel,Hans Salwender,Axel Benner,Marc S. Raab,Hartmut Goldschmidt,Niels Weinhold
出处
期刊:Blood Cancer Journal [Springer Nature]
卷期号:13 (1) 被引量:16
标识
DOI:10.1038/s41408-022-00772-9
摘要

Abstract Mass spectrometry (MS) is a promising tool for monitoring monoclonal protein in plasma cell dyscrasias. We included 480 transplant-eligible newly-diagnosed multiple myeloma (MM) patients from the GMMG-MM5 trial (EudraCT No. 2010-019173-16) and performed a retrospective MS analysis at baseline (480 patients) and at the pre-defined, consecutive time points after induction (444 patients), prior to maintenance (305 patients) and after one year of maintenance (227 patients). We found that MS negativity was significantly associated with improved progression-free survival (PFS) even in patients with complete response (CR) at all investigated follow-up time points. The prognostic impact was independent of established risk factors, such as the revised International Staging System. Combining MS and baseline cytogenetics improved the prediction of outcome: MS-positive patients with high-risk cytogenetics had a dismal PFS of 1.9 years (95% confidence interval [CI]: 1.6–2.3 years) from the start of maintenance. Testing the value of sequential MS prior to and after one year of maintenance, patients converting from MS positivity to negativity had an excellent PFS (median not reached) while patients converting from MS negativity to positivity progressed early (median 0.6 years, 95% CI: 0.3-not reached). Among patients with sustained MS positivity, the baseline high-risk cytogenetic status had a significant impact and defined a group with poor PFS. Combining minimal residual disease (MRD) in the bone marrow and MS allowed the identification of double negative patients with a favorable PFS (median 3.33 years, 95% CI: 3.08-not reached) and no overall survival events. Our study provides strong evidence that MS is superior to conventional response monitoring, highlighting the potential of MS to become a new standard. Our data indicate that MS should be performed sequentially and combined with baseline disease features and MRD to improve its clinical value. Clinical Trials Register: EudraCT No. 2010-019173-16

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
木雨亦潇潇完成签到,获得积分10
3秒前
香蕉觅云应助nine2652采纳,获得10
5秒前
量子星尘发布了新的文献求助10
9秒前
芳华如梦完成签到 ,获得积分10
11秒前
11秒前
12秒前
12秒前
土豆丝完成签到 ,获得积分10
12秒前
琦琦完成签到,获得积分10
21秒前
zzzz完成签到,获得积分20
26秒前
GEZIKU完成签到 ,获得积分10
27秒前
34秒前
41秒前
赵三岁发布了新的文献求助10
48秒前
wwb完成签到,获得积分10
51秒前
55秒前
56秒前
肯德基没有黄焖鸡完成签到 ,获得积分10
56秒前
能干冰露完成签到,获得积分10
59秒前
牛奶拌可乐完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助30
1分钟前
周小鱼完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
老张完成签到,获得积分10
1分钟前
1分钟前
zhugao完成签到,获得积分10
1分钟前
1分钟前
南风知我意完成签到,获得积分10
1分钟前
朴实寻琴完成签到 ,获得积分10
1分钟前
可可可爱完成签到 ,获得积分10
1分钟前
lsy完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
1分钟前
hwen1998完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
wwb发布了新的文献求助10
1分钟前
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038029
求助须知:如何正确求助?哪些是违规求助? 3575740
关于积分的说明 11373751
捐赠科研通 3305559
什么是DOI,文献DOI怎么找? 1819224
邀请新用户注册赠送积分活动 892652
科研通“疑难数据库(出版商)”最低求助积分说明 815022